» Articles » PMID: 37720607

Drug Delivery System for Controlled Release of Empagliflozin from Alginate-chitosan Nanocarrier System

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

A biocompatible nanocarrier system was prepared in this research through the reaction of calcium alginate (CA) with chitosan (CS). The structure of developed nanocarriers (CS-CA) was characterized by thermogravimetric analysis (TGA), Fourier transforms infrared (FT-IR) spectroscopy, field emission scanning electron microscopy (FE-SEM), X-ray diffraction (XRD) atomic force microscopy (AFM), and transmission electron microscopy (TEM). Swelling properties of CS-CA and CA, and their ability for loading and in vitro release of empagliflozin (EMP) were also investigated. The results showed the higher loading capacity of CS-CA compared to CA. For both nanocarriers, the drug release was higher at neutral pH (7.4 and 6.8) when compared to acidic pH (1.2). Despite the higher release of CA than CS-CA, the latter exhibited a favorable sustained drug release in all pH levels. As a result, CS-CA nanocarrier (EMP@CS-CANC) can be suggested as a new candidate for colon drug delivery of EMP.

Citing Articles

Discerning computational, in vitro and in vivo investigations of self-assembling empagliflozin polymeric micelles in type-2 diabetes.

Wagh P, Savaliya S, Joshi B, Vyas B, Kuperkar K, Lalan M Drug Deliv Transl Res. 2024; 14(12):3568-3584.

PMID: 39103594 DOI: 10.1007/s13346-024-01658-y.


pH responsive curcumin released from urea-amine group functionalized mesoporous organosilica nanoparticles.

Arli O, Gok Y, Gok H Turk J Chem. 2024; 47(6):1518-1528.

PMID: 38544702 PMC: 10965168. DOI: 10.55730/1300-0527.3632.

References
1.
Kumar S, Bhanjana G, Verma R, Dhingra D, Dilbaghi N, Kim K . Metformin-loaded alginate nanoparticles as an effective antidiabetic agent for controlled drug release. J Pharm Pharmacol. 2016; 69(2):143-150. DOI: 10.1111/jphp.12672. View

2.
Zelniker T, Wiviott S, Raz I, Im K, Goodrich E, Bonaca M . SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet. 2018; 393(10166):31-39. DOI: 10.1016/S0140-6736(18)32590-X. View

3.
Das R, Kasoju N, Bora U . Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine. 2009; 6(1):153-60. DOI: 10.1016/j.nano.2009.05.009. View

4.
Hua S, Ma H, Li X, Yang H, Wang A . pH-sensitive sodium alginate/poly(vinyl alcohol) hydrogel beads prepared by combined Ca2+ crosslinking and freeze-thawing cycles for controlled release of diclofenac sodium. Int J Biol Macromol. 2010; 46(5):517-23. DOI: 10.1016/j.ijbiomac.2010.03.004. View

5.
Al-Hashimi N, Babenko M, Saaed M, Kargar N, ElShaer A . The Impact of Natural and Synthetic Polymers in Formulating Micro and Nanoparticles for Anti-Diabetic Drugs. Curr Drug Deliv. 2020; 18(3):271-288. DOI: 10.2174/1567201817666200810111726. View